CHG-2022-0267
Facility Change for Lecanemabix. Formulation Change for Lecanemabix — critical change. Impacts 4 markets and 3 variations.
Change Number
CHG-2022-0267
Type
Facility Change
Product
Status
Failed
Owner
Tomoko Ikeda
Initiated
2023-01-20
Description
Formulation Change for Lecanemabix — critical change
Impacted Markets (4)
FR — FranceTR — TurkeyPL — PolandSE — Sweden
Impacted Modules
3.2.P5.3.53.2.P.32.3.P
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|